RankAlpha logo
Back to Rankings

CGEM

Cullinan TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
CGEM vs peer average
44/100
CGEM vs. peer average (D vs. D)
Grade spread
A 1 · B 1 · C 1 · D 5 · F 2
Graded peers loaded
Coverage
10 graded
91% of tracked

Peer overview

ESPR is the first available peer comparator.

Broader small-cap biotech comp with regulatory and execution sensitivity; useful as a volatility/market-cap reference, not as a direct operating peer.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerESPR
CGEM
Cullinan Therapeutics
ESPR
Peer
Grade
D
-
Momentum
9
-
Value
41
-
Sentiment
55
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Unrated

Grade position vs ESPR

CGEM / ESPR
Grade Position
Below peers
CGEM vs. peer average (D vs. D)
44/100
Momentum
9
-
Value
41
-
Sentiment
55
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CGEM
1
ESPR
ESPR
-
-
-
2
JANX
JANX
D
40/100
Even
3
LXRX
LXRX
D
40/100
Even
4
GLUE
Monte Rosa Therapeutics Inc Common
D
40/100
Even
5
JBIO
Jade Biosciences Inc Common
D
40/100
Even
ESPR is the first peer returned for this comparison set.